Clinical Trials

Adenocarcinoma of Lung, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01996098 2024-09-05

ICTAN

Phase 3 Terminated

251 enrolled

Phase 2 Active not recruiting

Lung Neoplasms

NCT05007938 2024-08-23

Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT06517953 2024-07-25

IcomBine

Phase 2 Recruiting

23 enrolled

Non-small Cell Lung Cancer Metastatic

NCT06041776 2023-09-22

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

Phase 3 Recruiting

570 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05514314 2022-08-24

A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02044328 2022-02-08

ICAPE

Phase 2 Completed

79 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05132985 2021-12-10

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05104788 2021-11-03

NeoIpower

Phase 2 Recruiting

27 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02448797 2021-07-20

EVIDENCE

320 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03736837 2021-03-15

ALTER-L004

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04797806 2021-03-15

SAINT

206 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04575415 2020-10-20

BELLA

Unknown

272 enrolled

NSCLC

NCT02737774 2020-07-01

Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation

Adenocarcinoma of Lung

NCT02744664 2020-05-27

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Phase 4 Completed

Lung Neoplasms

NCT04058704 2019-08-15

SMART

296 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03992885 2019-06-20

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

70 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT03983811 2019-06-12

Adjuvant Chemotherapy With or Without Intercalated Icotinib

Phase NA Unknown

174 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02726568 2019-02-19

High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03766490 2019-01-30

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

Phase NA Unknown

66 enrolled

Non-Small-Cell Lung

NCT03754530 2018-11-27

Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation

162 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03749213 2018-11-21

Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung Cancer

36 enrolled

EGF-R Positive Non-Small Cell Lung Cancer

NCT03349203 2018-07-18

Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer

EGF-R Positive Non-Small Cell Lung Cancer

NCT03396185 2018-07-18

Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT02125240 2018-07-16

ICWIP

124 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT03151161 2018-06-07

Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

118 enrolled

Lung Neoplasms

NCT01534585 2018-04-17

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Phase 1/2 Completed

48 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03346811 2017-11-17

CHALLENGE

120 enrolled

Plasma EGFR Mutation-positive Lung Cancer

NCT02404675 2017-07-28

INCREASE

240 enrolled

NSCLC

NCT01963195 2017-05-08

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

Drug-Related Side Effects and Adverse Reactions

NCT03123484 2017-04-21

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01724801 2017-03-01

BRAIN

Phase 3 Completed

176 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02960607 2016-11-18

High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC

25 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02961270 2016-11-11

Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation

Carcinoma, Non-Small-Cell Lung

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

330 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

67 enrolled

NSCLC

NCT02738983 2016-04-14

RT Plus EGFR-TKI for Wild-type NSCLC

22 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

250 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02375581 2016-03-22

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

130 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT01646450 2015-09-09

First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01707329 2015-09-09

Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment

180 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01843647 2015-07-15

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01926171 2015-07-15

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02062515 2015-07-15

Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency

Carcinoma, Non-Small-Cell Lung

NCT01720901 2015-05-22

Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy

Phase 4 Suspended

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02027090 2015-05-22

High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease

64 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02278458 2015-05-22

Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

Phase 1 Unknown

24 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02430974 2015-04-30

Chemotherapy of NSCLC With or Without Icotinib

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02103257 2015-04-29

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma